Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan 14;11(1):1.
doi: 10.1186/1477-5956-11-1.

Unrestrictive identification of post-translational modifications in the urine proteome without enrichment

Affiliations

Unrestrictive identification of post-translational modifications in the urine proteome without enrichment

Liu Liu et al. Proteome Sci. .

Abstract

Background: Research on the human urine proteome may lay the foundation for the discovery of relevant disease biomarkers. Post-translational modifications (PTMs) have important effects on the functions of protein biomarkers. Identifying PTMs without enrichment adds no extra steps to conventional identification procedures for urine proteomics. The only difference is that this method requires software that can conduct unrestrictive identifications of PTMs. In this study, routine urine proteomics techniques were used to identify urine proteins. Unspecified PTMs were searched by MODa and PEAKS 6 automated software, followed by a manual search to screen out in vivo PTMs by removing all in vitro PTMs and amino acid substitutions.

Results: There were 75 peptides with 6 in vivo PTMs that were found by both MODa and PEAKS 6. Of these, 34 peptides in 18 proteins have novel in vivo PTMs compared with the annotation information of these proteins on the Universal Protein Resource website. These new in vivo PTMs had undergone methylation, dehydration, oxidation, hydroxylation, phosphorylation, or dihydroxylation.

Conclusions: In this study, we identified PTMs of urine proteins without the need for enrichment. Our investigation may provide a useful reference for biomarker discovery in the future.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Rossing K, Mischak H, Rossing P, Schanstra JP, Wiseman A, Maahs DM. The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy. Proteomics Clin Appl. 2008;2:997–1007. doi: 10.1002/prca.200780166. - DOI - PubMed
    1. Ahmed N, Paul J, Hornalley T, JAdidi R, Paul J, Eisswenger B, Scott K, Owell H. Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes. Diabetes Care. 2005;28:2465–2471. doi: 10.2337/diacare.28.10.2465. - DOI - PubMed
    1. Vivekanandan Giri A, Slocum JL, Buller CL, Basrur V, Ju W, Pop-Busui R, Lubman DM, Kretzler M, Pennathur SM. Urine Glycoprotein Profile Reveals Novel Markers for Chronic Kidney Disease. Int J Proteomics. 2011. p. 214715. - DOI - PMC - PubMed
    1. Christensen B, Petersen TE, Sørensen ES. Posttranslational modification and proteolytic processing of urinary osteopontin. Biochem Soc. 2008;411:53–61. - PubMed
    1. Ye B, Skates S, Mok SC. et al.Proteomic-Based Discovery and Characterization of Glycosylated Eosinophil-Derived Neurotoxin and COOH-Terminal Osteopontin Fragments for Ovarian Cancer in Urine. Clin Cancer Res. 2006;12:432–441. doi: 10.1158/1078-0432.CCR-05-0461. - DOI - PubMed

LinkOut - more resources